過活動膀胱を伴う良性前立腺肥大の治療のための抗コリン作動薬併用α遮断薬を用いたランダム化比較試験

文献

J-GLOBAL ID：201102237881851660 整理番号：11A0845247

Randomized Controlled Trial to Treat Benign Prostatic Hyperplasia with Overactive Bladder Using an Alpha-blocker Combined with Anticholinergics

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=11A0845247&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0845247&from=J-GLOBAL&jstjournalNo=W2283A") }}

著者 (4件)： , , ,
資料名：
巻： 3 号： 1 ページ： 29-35 発行年： 2011年04月
JST資料番号： W2283A ISSN： 1757-5664 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：オーストラリア (AUS) 言語：英語 (EN)

過活動膀胱を伴う良性前立腺肥大に対するα遮断薬タムスロシンと...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0845247&from=J-GLOBAL&jstjournalNo=W2283A") }}

泌尿器作用薬の臨床への応用 , 泌尿生殖器疾患の薬物療法

引用文献 (11件)：

Saitoh H, Yamada T, Oshima H et al. A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence. Jpn J Urol Surg 1999; 12: 525-36.
Sugiyama T, Shimizu N, Yoshioka N, Hanai S. Matsumoto S, Uemura H. The treatment of overactive bladder symptoms related to benign prostatic hyperplasia with an anticholinergic agents. JJpn NeurogenicBladder Soc 2004; 15: 191-7.
McConnell J, Abrams P. Khoury S. Recommendations of the international scientific committee: Evaluation and treatment of lower urinary tract symptoms (LUTS) in older men.6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases, June 24-27 2005, Paris, France: 2006; 387-99.
Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Havendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A Randomized controlled trial. J Am Med Assoc 2006; 96: 2319-30.
Kaplan SA, McCammon K, Fincher R, Fakhoury A, He W. Safety and tolerability of solifenacin add-on therapy to ablocker treated men with residual urgency and frequency. J Urol 2009; 182: 2825-30.

, , , , , ,

前のページに戻る